We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Off-Label Communications Policy Review Underway at U.S. FDA
Off-Label Communications Policy Review Underway at U.S. FDA
January 5, 2012
In response to a citizen petition, the U.S. Food and Drug Administration (FDA) is seeking public input on how it should regulate scientific exchanges on off-label uses for medical products.
To View This Article:
Login
Subscribe To International Medical Device Regulatory Monitor